Based on the proteomic analysis of serum EVs in patients and functional cell culture studies, we found that RAB21 in serum EVs might be a discriminant marker for FTC and that it could play an important role in the malignant phenotype of FTC. Here, RAB21 is linked to thyroid cancer, nonmedullary, 2.